Trial NCT05461794

View at ClinicalTrials.gov 
Org. Study IDs: BGB-A317-Sitravatinib-203
Secondary IDs: CTR20222088

Last trial update was posted on 2024-03-04

MeSH Interventions

Docetaxel Irinotecan Tislelizumab

MeSH Conditions

Carcinoma Carcinoma, Squamous Cell Esophageal Squamous Cell Carcinoma

Other Conditions


Stopping Reasons

Due to modification of company strategy.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID